Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
HIV care cascade at Kaiser Permanente varies by sex and age

Though there has been improving performance of healthcare delivery at each point of the HIV care cascade, from linkage to care through viral suppression, "success varies significantly by

Published
2 hours ago
By
Theo Smart
Behavioural and financial incentives may improve HIV treatment outcomes

While making medications free can remove barriers to access for individuals who cannot pay for treatment, data suggest that for most people accessing care in industrialised countries, "making

Published
3 hours ago
By
Theo Smart
GlaxoSmithKline weighs an IPO for HIV-focused ViiV as it sharpens the budget axe

In the preamble to GSK's latest earnings statement, CEO Andrew Witty heralded the progress of ViiV, majority-owned by his company, since its foundation 5 years ago. Now, as ViiV enters the commercialization phase and continues building its pipeline, it might benefit from access to public markets, according to Witty. What that might mean in specific terms remains up in the air, and it's unclear whether GSK is considering selling off shares of only its own stake in the business.

Published
19 hours ago
From
FierceBiotech
Ireland: Hepatitis C drug to be made available

Minister for Health Leo Varadkar is to make available potentially life-saving treatments for hepatitis C – provided agreement on price can be reached with the manufacturers.

Published
23 hours ago
From
The Irish Times
2014 Report on Tuberculosis Research Funding Trends, 2005–2013

Worldwide, governments, foundations, and companies invested US$676.7 million in research to develop new drugs, vaccines, and diagnostics against tuberculosis (TB) in 2013—barely one-third of the US$2 billion that experts estimate the world must spend each year to end the global TB epidemic—according to an analysis released today by Treatment Action Group (TAG).

Published
23 hours ago
From
TAG
Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs

Advocates argue that the proposed criteria are dangerous for people living with the deadly liver disease.

Published
23 hours ago
From
Poz magazine news
WHO recommends steps to improve HIVAIDS control in Estonia

Estonia is among 5 European Union/European Economic Area countries with the highest rates of HIV– 24.6 per 100 000 populations in 2013. While the number of new HIV cases has been decreasing in Estonia since 2001, more needs to be done to address shortcomings in HIV/AIDS surveillance, treatment and care in order to halt the epidemic.

Published
21 October 2014
From
World Health Organization
Uganda fails to keep up with demand for HIV drugs

Despite a remarkable increase in access to HIV treatment over the last decade, the number of people in need of antiretroviral drugs in Uganda continues to outpace the response.

Published
20 October 2014
From
Key Correspondents
Mark Heywood: Ebola’s rapid death march - It’s time we learnt

Ebola and HIV are closely related in their social pathogenesis. The spread of both viruses is directly related to appalling governance of public heath systems and social inequality. Their control and treatment boils down to issues of democracy, equality and good governance.

Published
20 October 2014
From
Daily Maverick
Juncker seen making U-turn on medicines policy

Jean-Claude Juncker has ceded to pressure from MEPs and abandoned his plan to return control of medicines and pharmaceutical products to the Industry Commissioner. This responsibility will instead remain in the hands of the Health Commissioner.

Published
17 October 2014
From
EurActiv
← First12345...448Next →

Filter by country